BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Sep 29, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-09-28

Reporting Person: Cooper Jeffrey H (SVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-09-28	Common Stock	M	18379	$17.54	Acquired	58255	Direct
2011-09-28	Common Stock	S	18379	$32.00	Disposed	39876	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-09-28	Stock Option (right to buy)	$17.54	M	18379	Disposed	2016-11-19	Common Stock (18379)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 7, 2011.

F2: Original option grant vested 6/48ths on May 20, 2007 and 1/48th on the 20th of every month thereafter.